,U.S. biopharmaceutical companies,Year-to-date stock performance
0,Vir Biotechnology Inc.,279%
1,Inovio Pharmaceuticals Inc.,278.2%
2,Moderna Inc.,45.7%
3,Regeneron Pharmaceuticals Inc.,27.8%
4,Gilead Science Inc.,17.6%
5,Sanofi,-4.3%
6,Johnson & Johnson,-4.8%
7,Takeda Pharmaceutical Company Ltd.,-8.7%
8,GlaxoSmithKline,-12.8%
